News >

BiTEs, CAR T-Cell Therapy Enhance ALL Armamentarium, But Questions Remain

Brittany Cote
Published: Wednesday, Jan 22, 2020

Lloyd Damon, MD, clinical professor in the Department of Medicine, director of Hematologic Malignancies and Bone Marrow Transplant, and the Robert O. and Angela W. Johnson Endowed Chair in Hematopoietic Malignancies, UCSF Helen Diller Family Comprehensive Cancer Center

Lloyd Damon, MD

Novel treatments, including CAR T-cell therapy and bispecific T-cell engagers (BiTEs), have helped revolutionize the treatment of patients with acute lymphoblastic leukemia (ALL), but researchers continue to refine use of these modalities, according to Lloyd Damon, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication